RESUMO
BACKGROUND: Alpha-Glutathione S-transferase (α-GST) is a liver enzyme which showed properties making it useful in assessment of liver cell damage. A number of studies demonstrated its early elevation in different hepatic insults, but its pattern in HCV was controversial. Consequently, we planned this work to study the significance of Serum Alpha-Glutathione S-Transferase (α-GST) assessment in hepatitis C patients with different alanine aminotransferase (ALT) patterns. METHODS: Sixty-five untreated male patients with history of hepatitis C virus (HCV) positive antibodies and 21 healthy age- and sex-matched control subjects were enrolled in this study. Sera were collected for confirmation of the presence of HCV antibodies (by ELISA) as well as for assessment of the levels of α-GST, ALT, aspartate aminotransferase, alkaline phosphatase, gamma glutamyl-transferase, total proteins, albumin and HCV RNA. HCV RNA was detected by the reverse transcription polymerase chain reaction (RT-PCR). Based on ALT level, patients were divided into three groups. Twelve patients with normal ALT levels (NALT), 29 with near normal ALT levels (NNALT), and 24 with high ALT levels (HALT). All data were statistically analyzed for significance and correlation as well as sensitivity, specificity, positive and negative predictive values. RESULTS: The mean value of α-GST in HCV patients was significantly higher compared to the control with 82% sensitivity, 85% specificity, 98% positive predictive value and 63% negative predictive value. These results were more or less similar to the results of ALT and higher than the results of all the other assayed liver function tests. The sensitivity, and positive and negative predictive values of α-GST were lower than aminotransferases, but higher than the other assayed liver function tests in NNALT and HALT groups. Nevertheless, in NALT, these parameters were higher for α-GST than all the other assayed liver function tests including aminotransferases. CONCLUSIONS: Assay of α-GST has an adjuvant in evaluation of liver cell damage in HCV patients. However, its role is much more valuable in patients with normal aminotransferases for early detection of liver cell damage.
RESUMO
Investigators tried to correlate clinical presentation of giardiasis to the different genotypes, but controversial data were described through the last decade. The clinical manifestations of 89 Giardia patients were classified into:- GI: 52 symptomatic patients and GII: 37 asymptomatic patients. Genetic characterization of G. lamblia of the patients' fecal samples was performed by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) technique b using triose phosphate isomerase gene (tpi). Forty-two patients had genotype A1 (47.19%), 16 had genotype A2 (17.98%), 10 had genotype B (11.23%) and 19 had mixed genotype infection (21.35%). However, PCR-RFLP failed to determine Giardia genotype of only two cases (2.25%). The 20 control fecal samples obtained from healthy subjects showed negative results for G. lamblia by PCR-RFLP method. Of 52 cases in GI, the prevalence genotype A1 was 44.23%, genotype A2 was 19.23%, genotype B was 13.46%, mixed genotype infection was 21.15% and undetermined genotype was 1.92% as compared to 51.35%, 16.21%, 8.11%, 21.62% and 2.70% in GII, respecttively. There was no significant difference between both groups as regard the different Giardia genotypes (p>0.05). Statistical analysis of each symptom in different genotypes revealed insignificant (p>0.05). The results denied any correlation between G. lamblia genotype and the clinical presentation of giardiasis.
Assuntos
Fezes/parasitologia , Giardia lamblia/genética , Giardíase/parasitologia , Reação em Cadeia da Polimerase/métodos , Polimorfismo de Fragmento de Restrição , Adolescente , Adulto , Animais , Criança , DNA de Protozoário/química , DNA de Protozoário/genética , Egito/epidemiologia , Feminino , Genótipo , Giardia lamblia/classificação , Giardia lamblia/isolamento & purificação , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Sensibilidade e Especificidade , Triose-Fosfato Isomerase/genéticaRESUMO
BACKGROUND: Little information is known about telomerase expression in the chronic benign hyperproliferative skin disease, psoriasis. Further studies are still required to investigate its usefulness as a biomarker of this skin disorder. AIM: To investigate the expression of human telomerase reverse transcriptase (hTERT) in psoriatic lesional skin and its relation to disease severity. METHODS: The levels of hTERT-mRNA were quantified using real time RT-PCR in lesional versus nonlesional skin specimens from 24 psoriatic patients. RESULTS: The expression of hTERT was detected in 16 psoriatic lesional specimens (66.7%), but in none of the normal skin. There was no relation between hTERT expression level and age of the patient or the duration of the disease. Among hTERT-positive patients, a significant positive correlation was observed between hTERT-mRNA levels and both the Psoriasis Area-and-Severity Index (PASI) and scaling scores (p = 0.012 & p = 0.006, respectively). CONCLUSION: Telomerase mRNA is detectable in lesional skin of most psoriatic patients and correlates with the severity of the disease and the rate of epidermal proliferation.